Ignite Creation Date:
2025-12-25 @ 5:09 AM
Ignite Modification Date:
2026-03-28 @ 3:43 PM
Study NCT ID:
NCT05377827
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-04-29
First Post:
2022-05-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies
Sponsor:
Washington University School of Medicine
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | T-Cell Non-Hodgkin Lymphoma | View |
| None | Acute Myeloid Leukemia | View |
| None | Angioimmunoblastic T-cell Lymphoma | View |
| None | Enteropathy-Associated T-Cell Lymphoma | View |
| None | Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma | View |
| None | Peripheral T Cell Lymphoma | View |
| None | Anaplastic Large Cell Lymphoma | View |
| None | Adult T Cell Leukemia | View |
| None | Adult T Cell Lymphoma | View |
| None | T Cell Prolymphocytic Leukemia | View |
| None | Extranodal NK/T-cell Lymphoma | View |
| None | Transformed Mycosis Fungoides | View |
| None | Sezary Syndrome | View |
| None | Primary Cutaneous Gamma-Delta T-Cell Lymphoma | View |
| None | Hepatosplenic T-cell Lymphoma | View |
Keywords: